<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9301549</journal-id>
<journal-id journal-id-type="pubmed-jr-id">8482</journal-id>
<journal-id journal-id-type="nlm-ta">Exp Dermatol</journal-id>
<journal-id journal-id-type="iso-abbrev">Exp. Dermatol.</journal-id>
<journal-title-group>
<journal-title>Experimental dermatology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0906-6705</issn>
<issn pub-type="epub">1600-0625</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26660334</article-id>
<article-id pub-id-type="pmc">5084907</article-id>
<article-id pub-id-type="doi">10.1111/exd.12914</article-id>
<article-id pub-id-type="manuscript">NIHMS824475</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Maternal IL-6 can cause T-cell-mediated juvenile alopecia by non-scarring follicular dystrophy in mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>Stephen E. P.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maus</surname>
<given-names>Rachel L. G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Davis</surname>
<given-names>Tessa R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sundberg</surname>
<given-names>John P.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gil</surname>
<given-names>Diana</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schrum</surname>
<given-names>Adam G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA</aff>
<aff id="A2"><label>2</label>The Jackson Laboratory, Bar Harbor, ME, USA</aff>
<author-notes>
<corresp id="CR1"><italic>Correspondence</italic>: Adam G. Schrum, PhD and Stephen E. P. Smith, Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, 55905 USA, Tel.: +507 255 5919, Fax: +507 284 1637, <email>schrum.adam@mayo.edu</email>; <email>seps@uw.edu</email></corresp>
<fn fn-type="present-address" id="FN1">
<label>*</label>
<p id="P1">Current address: Seattle Childrenâ€™s Hospital, University of Washington, Seattle, WA, USA</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>22</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>28</day>
<month>10</month>
<year>2016</year>
</pub-date>
<volume>25</volume>
<issue>3</issue>
<fpage>223</fpage>
<lpage>228</lpage>
<!--elocation-id from pubmed: 10.1111/exd.12914-->
<permissions>
<license>
<license-p>This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p id="P2">Aiming to decipher immunological mechanisms of the autoimmune disorder alopecia areata (AA), we hypothesized that interleukin-6 (IL-6) might be associated with juvenile-onset AA, for which there is currently no experimental model. Upon intramuscular transgenesis to overexpress IL-6 in pregnant female C57BL/6 (B6) mice, we found that the offspring displayed an initial normal and complete juvenile hair growth cycle, but developed alopecia around postnatal day 18. This alopecia was patchy and reversible (non-scarring) and was associated with upregulation of <italic>Ulbp1</italic> expression, the only mouse homolog of the human AA-associated ULBP3 gene. Alopecia was also associated with inflammatory infiltration of hair follicles by lymphocytes, including alpha-beta T cells, which contributed to surface hair loss. Despite these apparently shared traits with AA, lesions were dominated by follicular dystrophy that was atypical of human AA disease, sharing some traits consistent with B6 alopecia and dermatitis. Additionally, juvenile-onset alopecia was followed by complete, spontaneous recovery of surface hair, without recurrence of hair loss. Prolonging exposure to IL-6 prolonged the time to recovery, but once recovered, repeating high-dose IL-6 exposure <italic>de novo</italic> did not re-induce alopecia. These data suggest that although substantial molecular and cellular pathways may be shared, functionally similar alopecia disorders can occur via distinct pathological mechanisms.</p>
</abstract>
<kwd-group>
<kwd>alopecia areata</kwd>
<kwd>B6 alopecia and dermatitis</kwd>
<kwd>interleukin-6</kwd>
<kwd>juvenile onset</kwd>
<kwd>lymphocyte</kwd>
<kwd>maternal immune activation</kwd>
<kwd>T cell</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>